Krynica Vitamin S.A. (WSE:KVT)

Krynica Vitamin Statistics

Total Valuation

Krynica Vitamin has a market cap or net worth of PLN 126.79 million. The enterprise value is 164.68 million.

Market Cap	126.79M
Enterprise Value	164.68M

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date	Nov 20, 2025
Ex-Dividend Date	Jul 10, 2025

Share Statistics

Krynica Vitamin has 12.25 million shares outstanding.

Current Share Class	12.25M
Shares Outstanding	12.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	1.92%
Float	1.61M

Valuation Ratios

The trailing PE ratio is 9.78.

PE Ratio	9.78
Forward PE	n/a
PS Ratio	0.34
PB Ratio	1.23
P/TBV Ratio	1.28
P/FCF Ratio	18.48
P/OCF Ratio	7.87
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.74, with an EV/FCF ratio of 24.00.

EV / Earnings	12.69
EV / Sales	0.44
EV / EBITDA	4.74
EV / EBIT	7.97
EV / FCF	24.00

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.37.

Current Ratio	0.98
Quick Ratio	0.58
Debt / Equity	0.37
Debt / EBITDA	1.09
Debt / FCF	5.53
Interest Coverage	8.72

Financial Efficiency

Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 9.35%.

Return on Equity (ROE)	13.22%
Return on Assets (ROA)	5.90%
Return on Invested Capital (ROIC)	9.35%
Return on Capital Employed (ROCE)	16.97%
Revenue Per Employee	1.08M
Profits Per Employee	37,276
Employee Count	348
Asset Turnover	1.71
Inventory Turnover	8.44

Taxes

In the past 12 months, Krynica Vitamin has paid 2.04 million in taxes.

Income Tax	2.04M
Effective Tax Rate	13.57%

Stock Price Statistics

The stock price has increased by +4.97% in the last 52 weeks. The beta is 0.03, so Krynica Vitamin's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+4.97%
50-Day Moving Average	10.18
200-Day Moving Average	9.72
Relative Strength Index (RSI)	55.43
Average Volume (20 Days)	37,017

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Krynica Vitamin had revenue of PLN 374.70 million and earned 12.97 million in profits. Earnings per share was 1.06.

Revenue	374.70M
Gross Profit	65.21M
Operating Income	20.67M
Pretax Income	15.01M
Net Income	12.97M
EBITDA	34.75M
EBIT	20.67M
Earnings Per Share (EPS)	1.06

Balance Sheet

The company has 74,000 in cash and 37.96 million in debt, giving a net cash position of -37.89 million or -3.09 per share.

Cash & Cash Equivalents	74,000
Total Debt	37.96M
Net Cash	-37.89M
Net Cash Per Share	-3.09
Equity (Book Value)	102.98M
Book Value Per Share	8.41
Working Capital	-1.41M

Cash Flow

In the last 12 months, operating cash flow was 16.11 million and capital expenditures -9.25 million, giving a free cash flow of 6.86 million.

Operating Cash Flow	16.11M
Capital Expenditures	-9.25M
Free Cash Flow	6.86M
FCF Per Share	0.56

Margins

Gross margin is 17.40%, with operating and profit margins of 5.52% and 3.46%.

Gross Margin	17.40%
Operating Margin	5.52%
Pretax Margin	4.01%
Profit Margin	3.46%
EBITDA Margin	9.27%
EBIT Margin	5.52%
FCF Margin	1.83%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.61%.

Dividend Per Share	0.27
Dividend Yield	2.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	25.50%
Buyback Yield	n/a
Shareholder Yield	2.61%
Earnings Yield	10.23%
FCF Yield	5.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Krynica Vitamin has an Altman Z-Score of 2.88 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.88
Piotroski F-Score	8